Biomedical Informatics and Digital Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
JAMA Psychiatry. 2023 Nov 1;80(11):1121-1130. doi: 10.1001/jamapsychiatry.2023.2289.
Determining the association between drug use and suicide is complicated but can help to inform targeted suicide prevention strategies.
To examine the substances prevalent in poisoning- and nonpoisoning-related suicides in Australia.
DESIGN, SETTING, AND PARTICIPANTS: This was a multiple-year, cross-sectional study of suicides from July 2013 to October 2019 in Australia with toxicology data available in a national coronial database. The cause of death was classified as poisoning related if any type of poisoning was determined by the coroner to contribute to the cause of death. Prevalence ratios (PRs) were calculated to compare substance detection in poisoning- vs nonpoisoning-related suicides. Data were analyzed from October 2021 to April 2023.
All substances detected in decedents at the time of death according to toxicology reports were recorded.
MAIN OUTCOME(S) AND MEASURE(S): The most common individual substances and substance classes were identified. From these, blood concentrations of substances of interest were analyzed, and the most commonly occurring combinations of substance classes were listed.
Toxicology was performed on 13 664 suicide decedents (median [IQR] age, 44 [31-57] years; 10 350 male [76%]). From these, 3397 (25%) were poisoning-related suicides (median [IQR] age, 50 [38-63] years; 2124 male [63%]). The remainder were classified as nonpoisoning-related suicides (median [IQR] age, 42 [29-55] years; 8226 male [80%]). PRs for common medicine classes being detected in poisoning-related suicides compared with nonpoisoning-related suicides were as follows: antidepressants (PR, 1.63; 95% CI, 1.54-1.73), benzodiazepines (PR, 2.01; 95% CI, 1.90-2.13), nonopioid analgesics/anti-inflammatory drugs (PR, 1.88; 95% CI, 1.78-2.00), and opioids (PR, 2.72; 95% CI, 2.58-2.87). Alcohol (as ethanol ≥0.03 g/100 mL) was almost equally prevalent in poisoning- and nonpoisoning-related deaths (PR, 1.07; 95% CI, 1.01-1.14), whereas amphetamines (PR, 0.68; 95% CI, 0.61-0.77) and cannabinoids (PR, 0.67; 95% CI, 0.60-0.74) were detected more often in nonpoisoning-related suicides. Combinations of multiple sedative agents in poisoning-related suicides were common.
Both poisoning- and nonpoisoning-related suicide deaths featured a high prevalence of psychotropic medicines or potential intoxication, which suggests the association of suicide with poor mental health and substance misuse. Findings suggest that substances with a high involvement in poisoning-related suicides should be prescribed cautiously, including antidepressants that are toxic in overdose, sedatives, opioids, and potentially lethal combinations.
确定药物使用与自杀之间的关联很复杂,但可以帮助制定有针对性的预防自杀策略。
研究澳大利亚中毒和非中毒相关自杀中常见的物质。
设计、地点和参与者:这是一项多年度的横断面研究,纳入了 2013 年 7 月至 2019 年 10 月澳大利亚的自杀案例,这些案例在国家法医数据库中均有可用的毒理学数据。如果法医确定任何类型的中毒对死因有贡献,则将死因归类为中毒相关。计算了患病率比(PR)来比较中毒与非中毒相关自杀中物质的检出情况。数据分析于 2021 年 10 月至 2023 年 4 月进行。
根据毒理学报告记录了死亡时死者体内检测到的所有物质。
确定了最常见的个体物质和物质类别。从这些物质中,分析了有兴趣的物质的血液浓度,并列出了最常见的物质类别组合。
对 13664 名自杀死者进行了毒理学检测(中位数[IQR]年龄,44[31-57]岁;10350 名男性[76%])。其中,3397 例(25%)为中毒相关自杀(中位数[IQR]年龄,50[38-63]岁;2124 名男性[63%])。其余的被归类为非中毒相关自杀(中位数[IQR]年龄,42[29-55]岁;8226 名男性[80%])。与非中毒相关自杀相比,中毒相关自杀中常见药物类别的 PR 如下:抗抑郁药(PR,1.63;95%CI,1.54-1.73)、苯二氮䓬类(PR,2.01;95%CI,1.90-2.13)、非阿片类镇痛药/抗炎药(PR,1.88;95%CI,1.78-2.00)和阿片类药物(PR,2.72;95%CI,2.58-2.87)。酒精(乙醇≥0.03 g/100 mL)在中毒和非中毒死亡中几乎同样常见(PR,1.07;95%CI,1.01-1.14),而安非他命(PR,0.68;95%CI,0.61-0.77)和大麻素(PR,0.67;95%CI,0.60-0.74)在非中毒相关自杀中更常见。中毒相关自杀中常见多种镇静剂的组合。
中毒和非中毒相关自杀死亡都具有很高的精神药物或潜在中毒的流行率,这表明自杀与心理健康不良和物质滥用有关。研究结果表明,与中毒相关自杀有高关联的物质应谨慎开处方,包括在过量服用时有毒的抗抑郁药、镇静剂、阿片类药物和潜在致命的组合。